Peripheral Arterial Disease
📧 Sign up to get email alerts when something new happens for Peripheral Arterial Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-08-28EMA Authorised: Rivaroxaban Accord (rivaroxaban) — Accord Healthcare S.L.U.
The EMA authorised Accord Healthcare's rivaroxaban product (Rivaroxaban Accord) for multiple indications including acute coronary syndrome, …
-
FDA approval · 2023-09-07FDA Approved: CLOPIDOGREL — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) by Apotex Corp., under the ANDA, authorizing a modif…
-
FDA approval · 2022-03-31FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a ge…
-
FDA approval · 2020-12-18FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for cilostazol submitted by Teva Pharmaceuticals USA, Inc., resulting in an approved modificatio…
-
FDA approval · 2019-12-13FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for Clopidogrel Bisulfate from Radha Pharmaceuticals, Inc., confirming approval of their generic pro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-12FDA Approved: CLOPIDOGREL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for clopidogrel from Amneal Pharmaceuticals LLC under ANDA 203751, confirming changes to the approve…
-
FDA approval · 2019-04-03FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for clopidogrel bisulfate from Aurobindo Pharma Limited, confirming regulatory approval for this gen…
-
FDA approval · 2017-12-01FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA granted a supplemental approval for cilostazol by Chartwell RX, LLC under the ANDA process.
-
FDA approval · 2017-10-31FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for PLAVIX (clopidogrel) submitted by Sanofi-Aventis U.S. LLC. The approval concerns changes to the …
-
FDA approval · 2017-07-10FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Plavix (clopidogrel) by Sanofi-Aventis U.S. LLC, resulting in changes to the product labeling.
-
FDA approval · 2016-04-04FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for cilostazol from Chartwell RX, LLC.
-
CLINICAL_TRIALS approval · 2016-02-23Clinical Trial Update: Athrectomy and Drug Eluting Balloon Therapy (ADEBT) on the Femoral Popliteal Arteries
The Athrectomy with Drug Eluting Balloon Therapy (ADEBT) has been approved for marketing to treat Peripheral Arterial Disease in the femoral…
-
FDA approval · 2016-01-21FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for pentoxifylline filed by Rising Pharma Holdings, Inc., indicating an update to its regulatory…
-
FDA approval · 2015-07-16FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA lists a supplemental application for Plavix (clopidogrel) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2014-12-31FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Cilostazol (generic Cilostazol). This action typically involves u…
-
FDA approval · 2014-09-23FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cilostazol from Teva Pharmaceuticals USA, Inc., updating the labeling for the drug. This constit…
-
FDA approval · 2014-09-15FDA Approved: CLOPIDOGREL BISULFATE — Original Application (RADHA PHARMACEUTICALS, INC.)
FDA approved the original ANDA for clopidogrel bisulfate, a generic antiplatelet agent, expanding access to a therapy that reduces vascular …
-
FDA approval · 2014-03-04FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).
-
FDA approval · 2013-04-04FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Inc, for their generic clopidogr…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' clopidogrel bisulfate as an original application (ANDA), enabling a generic version of the antiplatel…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic clopidogrel; an antiplatelet agent used to reduce cardiovascular events in patients with acute coronary syndrome…
-
FDA approval · 2010-05-18FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for clopidogrel bisulfate, a generic version of clopidogrel. The ap…
-
FDA approval · 2007-10-22FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2007-01-12FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Pentoxifylline submitted by Rising Pharma Holdings, Inc., enabling continued marketing of th…
-
FDA approval · 2006-08-17FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.